Skip to main content
. 2021 Feb 12;13(4):761. doi: 10.3390/cancers13040761

Figure 6.

Figure 6

Characterization of TME with IHC markers. (a) CD45 expression: hematopoietic cells (both lymphocytes and macrophages). (b) CD163 expression: M2 macrophages. (c) PDL-1 expression: presence of positive tumor cells in the perivascular space. (d) CD34 expression: endothelial cells. Representative images captured from OSU Tissue Archives.